investment opportunity the future is within our grasp

INVESTMENT OPPORTUNITY

The Future is within Our Grasp

2 1 . 1 2 . 2 0

Gra

sp A

S |

web

: gra

sp.g

lob

al

D E A L T E R M S

• Total Round Size : NOK 2.500.000

• Minimum Investment : NOK 100.000 per investor

• Pre-Money Valuation: NOK 21.000.000*

• Target: Primary existing investors and partners

• Runway: Q3 2021

* Pre-money last round 17.500.000 + equity raised last round 3.500.000 = post-money 21.000.000

Executive summary and Grasp strategy

Problem and solution

Business model and financials

Marketing, sales and competitions

Team

Target market and opportunities

Investment and use of funds

O V E R V I E W C O N T E N T

Problem Solution Market TeamOne in four experience mental health

problems during their lifetime and many experience pain and discomfort in

connection with both lifestyle diseases and health problems.

A common challenge for most people is understanding and communication about

their own condition. Today, forms, notebooks, or complicated computer tools are offered to map out how you feel. For many, this becomes too difficult. Without sufficient knowledge of how the user or

patient is doing, it is difficult to help.

Grasp you emotions – a diary without words.

With Grasp's advanced technology and simple functional design, anyone can

register experiences through squeezing. Grasp remembers when you squeezed, how

hard and for how long - as an imprint of what you experienced.

By loading data into the app and into the visualization tool, you get a complete

overview of all data. Then you can take a closer look at and analyze a specific episode,

a period and compare periods to look for trends and tendencies.

Grasp is trying to solve a global problem around communication of emotions.

B2B Somatic in Norway, with Clinics will be the primary Target Market for 2021. The company is also working on pilots in UK,

Nordics and Africa to identify product market- fit beyond Norway.

The company is planning to enter the B2C marked in 3rd quarter 2022, which is

expected to significantly increase sales.

Grasp has a highly competent team of inventors, scientists, developers, health

workers and experienced business people.

We also have several public and private partners. In 2021 we want to

strengthen in sales and market, carry out more research projects and further develop the concept in close dialogue

with our customers

Powered byGRASP AS

Current

Previous

E X E C U T I V E S U M M A R Y

W H O W E A R E

2012 (de facto), 2017 (de jure)

Bergen, Norway

Private

MedTech, HealthTech

A diary without words. Grasp your emotions. Communication re-imagened. Making subjective medical history objective. The Future is within Our Grasp

Ingvald Grindheim (CEO), Jørund Fjøsne (CSMO), Tormod Gjerde Opdal (CPO),Tor Gjøsæter (CRO), Aleksander Krzywinski (COO), Per Øystein Opdal (CMO)

www.grasp.global

Healthcare equipment - digital diagnostic and monitoring medical device(s)

Founded

Headquarters

Type

Industry

Statements

Key people

Website

Products

GRASP AS, a digital healthcare company, focuses on development, production and distribution of digital diagnostic andmonitoring medical device that facilitates communication of medical history between patients and clinicians, and enablespersonalized treatment. It operates in the major Scandinavian countries and Western Europe.

Grasp will help people globaly to communicate their emotions in a way no one ever have seen

OURVISION

STRATEGY - PURPOSE

Vision

Grasp will help people communicate what they feel. And be a natural part of treatment, both for patient and therapist

Mission

Goal

To provide healthcare market with reliable digital solutions, enhance accuracy and effectiveness of medical treatment, and enable best patient experienceTo “Grasp” will be a known and

common way to register and communicate your feelings

G R A S P - A D I A R Y W I T H O U T W O R D S

«Humans find it cognitively challenging to recodean experience into either numerical, visual,

analogue or verbal label modes.

This is especially true for children and non-native speakers. There is plenty og evidence for cultural

differences in understanding and reporting ofexperiences including both over-reporting and

under-reporting.»

Ewa G TruchanowiczBusiness Development Director

Dignio Ltd.

Cognitive challenge to recode an experience

Asymmetric communication leads to different interpretation

Limited ability or willingness to memorize events and express verbally

Experience Time Recap experience Communicate experience

C U R R E N T S I T UAT I O N – P R O B L E M I N D E TA I L

TOO

LS

Diary DiaryApps

Forms FormsForms

1.Patient receives pain form from the doctor

2.Patient experiences pain throughout the day

3.Patient subsequently fills out pain form, having to remember details

4.Discussing the pain form, which may be lacking vital data

C U R R E N T S I T UAT I O N – P R O B L E M I N D E TA I L

TOO

LS

G R A S P – S O LV I N G T H E P R O B L E M

1.Patient recieves Grasp from the doctor and agree when to use it

2.Patient register symptoms directly in real-time using Grasp and monitors their data visually with Grasp Insight App

3.Discussing data using Grasp Insight for desktop

G R A S P – A N E W D I M E N S I O N TO PAT I E N T C O M M U N I C AT I O N

EventThe patient and doctor discusses a single event that lasted for longer than normal. What happened during this event?

PeriodHere they are reading the logs for a single day, where the patient has experienced issues in a period of approx. three hours.

A period consists of multiple events within a close timeframe.

TendenciesUsing a weekly view, they can see that the patient tend to register issues several days in a row at approximately the same period every day.

- Whether you are young or old, Grasp will help you communicate your emotions easily and in a way

no one has seen before.

G R A S P – C O M M U N I C AT I O N R E - I M A G E N E D

PAIN ADDICTION

|

DEPRESSION PANIC AND ANXIETY

SOMATICS

MENTAL HEALTH

PAT I E N T G R O U P S TA R G E T M A R K E T

Geografy/Sector

Providers2021 Q1-Q2 2021 Q3-Q4 2022 Q1-Q2 2022 Q3-Q4 2023

Somatics Mental Health Somatics Mental Health Somatics Mental Health Somatics Mental Health Somatics Mental Health

B2B

NORWAY

PublicSpesialisthelsetjenesten

-Pilot BT transfer-Pilot palliative

Forhelse projectPilot rehabSales pain

Anxiety Method

developmentAddiction

Refund Helfo

Method development

Refund Helfo

PrimærhelsetjenestenSingel case study

Research painSingel case study Research pain

Method development

Refund Helfo

Method development

Refund Helfo

Private

Organizations Pilot pain 2020Sales

KreftforeningSales

Org. painSales

MH org.Sales multiple organizations

GPs Pain Study GPs Pain Study GPsMethod

developmentRefund Helfo

Method development

Refund Helfo

Healthcare providers Research painResearch pain

Sales painResearch MH Sales MH

ABROAD

NORTH AFRICA

Clinical Pain studySales private

healthcare prvSales public healthcare

UKAspergillosis Trust

studyPilot private

clinicsSales private

healthcare prvSales public healthcare

NORDICDanderyd Hospital

OTHERS FDA

B2C

NORDICEarly adopter

campaignSales B2C

AFRICA Piloting Sales B2C

EUROPE Piloting Sales B2C

US Piloting

TA R G E T M A R K E T E N T R Y S T R AT E G Y

M A R K E T P O T E N T I A L

Serviceable Obtainable Market*

Serviceable Available Market

Total Addressable Market

Total Market Potential

Estimate of 10 000 users and 200 paying customers (B2B) Somatics and Mental Health

300 000 patients in Norway undergoing healthcare treatment in Somatics and Mental Health

Global smart diagnostic and monitoring medical device market

All patients undergoing medium-/long-term healthcare treatment where clinicians need to analyze patients’ medical history – in this region:

*Limited by the production, sales and financial capacity of the company (reasonable to capture within two years)

Criteria for selecting SAM:

• Highest need - value creation

• Highest willingness to accept the product

• Marketing reach• Lowest competition and

risks• Area where company has

highest expertise• Partners’ networks

Grasp AS

|

M A R K E T P OT E N T I A L

|

«Etter utallige møter forå diskutere innovasjoninnen psykisk helse, erGrasp det første prosjektetmed virkelig høg grad avnyskaping»

Dr. Paul MøllerVestre Viken

«For oss representerer Graspen liten revolusjon innene-helse»

Laila HagenDignio AS

«Ved å bruke GRASP kan man lett kartlegge og registrere symptomene og få en kvalitetssikret tilbakemelding som muliggjør raskere og bedre persontilpasset oppfølging»

Dr. Jens EspelandKommuneoverlege Sarpsborg kommune

«At last, real-time mentalhealth vital signsmonitoring»

Dr. John ShortBirmingham MentalHealth Trust

G R A S P VA LU E Q U OT E S

BASIS

+

Single user

Powered byGRASP AS

Current

Previous

PREMIUM

+

Single user + share

Kr 990 + 399/month

Powered byGRASP AS

Current

Previous +

ENTERPRISE

+

Kr 4.990/month/deptEnterprise Insight portal & admin

Kr 599/monthGrasp + Single user + share

Kr 990 + 299/month

P R I C I N G M O D E L S – F O C U S E D O N S U B S C R I P T I O N R E V E N U E S

B U S I N E S S M O D E L A T A G L A N C E

Human resources, patents, R&D, software, hardware,

production, operations

Powered byGRASP AS

Current

Previous

Digital diagnostic and monitoring medical device

VALUE CREATION

End user (patient)

Paying customer

Public and private clinicians/healthcare

Undergoing treatment most suitable for

product application

ONLINE

ORDERING

PORTAL

DIRECT SALES TEAM

VALUE DELIVERY

Physical device: 990 kr

BASIS: 299 kr

Recurring revenue model

PREMIUM App: 399 kr

ENTERPRISE: 4.990kr

VALUE CAPTUREFOR

TOFROM

Doctor / Therapist

Public and private clinicians/healthcare service

providers (B2B)

M A R K E T I N G A N D S A L E S P R O C E S S

LAUNCHPRE-LAUNCH POST-LAUNCH

ENGAGEMENT

• Website, Chat and Blog• Conferences and fairs

LOYALTY

• Website and Blog• Annual events• Community building

SERVICE

• Key account managers• Application management center• Chat, Phone and Email

PURCHASE

• Paying customer• Direct sales team and distributors• Online ordering portal • Phone and Email

C o m b i n i n g p r o d u c t l a u n c h f l o w w i t h c u s t o m e r j o u r n e y l a y e r s

+ STRATEGIC PARTNERSHIPS

AWARENESS

• References and WoM from product testing• Promoting concern through media and PR• Conferences and fairs

Grasp AS | web: grasp.global

M A N A G E M E N T T E A M

Tor Gjøsæter

CEO Research & Developement

Tormod Gjerde Opdal

Sales & Market

Ingvald Grindheim

Einar Austlid

Customer success

Alexander Krzywinski

Integrations, architecture

Jørund Fjøsne

Inventor, designer

Per Øystein Opdal

Medical officer

Eunice Hammond

Sales rep. Africa

G R A S P A D V I S O R Y B O A R D

Highly dedicated individuals with unique expertise in their field will advise Grasp.

Pål Vegard Hagen Ingvild LyhmannElin Grigoryan

Frode Guribye Lars Henrik Østevold

Psykologspesialist, privatMaster i Familieterapi og systemisk praksis

Sjøkrigsskolen og Handelshøyskolen

CEO – Daglig leder Blatchford

Professor. Institutt for informasjons- og medievitenskap,

UiB

PsykologPhD-stipendiat Kompetansesenter Helse

Bergen

P R O D U C T – A P P R O VA L S A N D PAT E N T S - I P R

Patent

Product: Pending application

.


IPR Strategy

Medical Device Approval of software (app.) in 2021

QMS according to ISO in 2021

Always checking for other possible approvals needed

CE-marked and Medical Device Approved 25.02.2020

Design: Approved

Trademark and design, EU: Approved

Trademark: Approved

Unit sales

Revenues vs Cost Valuation

0

500

1 000

1 500

2 000

2 500

3 000

3 500

Q1-21 Q2-21 Q3-21 Q4-21 Q1-22 Q2-22 Q3-22 Q4-22 Q1-23 Q2-23 Q3-23 Q4-23 Q1-24 Q2-24 Q3-24 Q4-24

Annual Recurring Revenues

0

5 000 000

10 000 000

15 000 000

20 000 000

25 000 000

30 000 000

35 000 000


0

5 000 000

10 000 000

15 000 000

20 000 000

25 000 000

30 000 000


#21 Mnok

F I N A N C I A L P R O J E C T I O N S

* Pre-money last round 17.500.000 + equity raised last round 3.500.000 = post-money 21.000.000

Real-time monitoringRetrospective monitoring

Analogue tools

Digital tools

C O M P E T I TO RS A N D C O M PA R AT I V E A DVA N TA G E A N A LY S I S

Diary

• Most competitors deliver retrospective monitoringsolutions

• Traditionally monitoringtools are highly analogue

• Grasp delivers a balancedreal-time solution withlow barrier for use

Grasp concept

Forms with NRS or other scales

Multiple applications for retrospective logging

2018

Prototype

2017

Grasp AS

established

2019 / 2020

Research Edition

Mid 2019

MVP

Mid 2020

Proof of

Concept

NEXT

Start 2020

CE & Medical Device

Grasp unit

End 2020

Produced

500 units

2012

Idea

Q3 2019

Production line established

2019

Innovation

Contract

Q1 2020

Pilot project

Patent Grasp

device


Q4 2020

Ready for

Clinical trials

Clinical

Trials GP

Sales to Health Care private

CE & Medical DeviceSoftware

Admin

web.app.

Pilot

Clinic

Grasp 2.0

ready

Sales to pilot customers

Pilot Business model

Clinical Trials

Clinic

Sales to Health Care public

Pilot

Hospital

DE

VE

LOP

ME

NT

SA

LES

PR

OO

F O

F

CO

NC

EP

T

H I S TO R Y A N D M I L E S TO N E S 2 0 1 7 - 2 0 2 0

Research Grants Capital raise

15 MNOKOther GrantsCapital raise

2,5 MNOK

FUN

DR

AIS

ING

Q1 2021 Q2 2021 Q3 2021 Q4 2021

O V E R V I E W U P C O M I N G F E AT U R E S

Powered byGRASP AS

Current

Previous

DIRECT FEEDBACK

CALIBRATION

Admin hospitals/clinics

LIVE MONITORING WIRELESS CHARGING

TREATMENT MODULES

ONLINE

ORDERING

PORTAL

Q1 2021

Q2 2021 Q4 2021

Q3 2021 2022

2022

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

Runway6 months

2020 2021 2022 2023

DealflowmNOK 0,9

Growth loan mNOK 2,0

Debt convertingmNOK 1,25

FundraisingmNOK 1,4

Loan INmNOK 2,4

FundraisingmNOK 2,5

FundraisingmNOK 20

FundraisingmNOK 15

Runway9 months

Runway12 months

Longer runway

VC or industrial owner in Q3-21

Goals

F U N D R A I S I N G 2 0 2 1 - 2 0 2 3

Value added

• Skattefunn 2020 – 0,5 MNOK

• NRS

• Pilot Health – 0,3 MNOK

• IPN

• Eurostars

U S E O F F U N D - 2 0 2 1 - OT H E R F U N D I N G

• Research and Development

• Human Resources

• Pilot studies

• Market entry Norway, Nordic, Africa

Grasp your emotions

investment opportunity the future is within our grasp

Documents